Veracyte Inc’s filing revealed that its Director KARIN EASTHAM acquired Company’s shares for reported $0.12 million on Jun 13 ’25. In the deal valued at $26.69 per share,4,590 shares were bought.
Then, MUNA BHANJI bought 4,589 shares, generating $122,480 in total proceeds.
Before that, Leite John sold 2,809 shares. Veracyte Inc shares valued at $76,410 were divested by the Chief Commercial Officer-CLIA at a price of $27.20 per share. As a result of the transaction, Leite John now holds 94,540 shares, worth roughly $2.52 million.
Craig Hallum initiated its Veracyte Inc [VCYT] rating to a Buy in a research note published on March 20, 2025; the price target was $45. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in early December from “a Buy” to “a Neutral”. Wolfe Research began covering VCYT with “an Outperform” recommendation on November 15, 2024. UBS started covering the stock on October 16, 2024. It rated VCYT as “a Buy”.
Price Performance Review of VCYT
On Monday, Veracyte Inc [NASDAQ:VCYT] saw its stock jump 0.76% to $26.64. Over the last five days, the stock has lost -4.34%. Veracyte Inc shares have fallen nearly -32.73% since the year began. Nevertheless, the stocks have risen 20.71% over the past one year. While a 52-week high of $47.32 was reached on 01/30/25, a 52-week low of $19.73 was recorded on 06/16/25.
Levels Of Support And Resistance For VCYT Stock
The 24-hour chart illustrates a support level at 26.02, which if violated will result in even more drops to 25.40. On the upside, there is a resistance level at 27.09. A further resistance level may holdings at 27.54.
The most recent change occurred on October 10, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
